A first: All respond to CAR-T therapy in a blood cancer study – STAT
STAT |
A first: All respond to CAR–T therapy in a blood cancer study
STAT HICAGO — Doctors are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that's on the rise. Although it's early and the study is small — 35 people — every patient responded and all but two were in … CAR T- Cell Therapy Could Be A Promising Treatment For Multiple Myeloma Cancer Therapy Shows High Remission Rates in Multiple Myeloma Gene-Based Therapy That Reprograms Immune Cells Offers Hope For Multiple Myeloma Cure |
